Panacos Pharmaceuticals Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
PANC has 53.64 million shares outstanding.
| Current Share Class | 53.64M |
| Shares Outstanding | 53.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 3.45.
| Current Ratio | 2.15 |
| Quick Ratio | 2.11 |
| Debt / Equity | 3.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.58 |
| Interest Coverage | -11.10 |
Financial Efficiency
Return on equity (ROE) is -168.83% and return on invested capital (ROIC) is -61.65%.
| Return on Equity (ROE) | -168.83% |
| Return on Assets (ROA) | -52.62% |
| Return on Invested Capital (ROIC) | -61.65% |
| Return on Capital Employed (ROCE) | -202.25% |
| Weighted Average Cost of Capital (WACC) | 13.38% |
| Revenue Per Employee | 2,415 |
| Profits Per Employee | -872,073 |
| Employee Count | 41 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -17.14 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 48.13 |
| Average Volume (20 Days) | 15,423 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PANC had revenue of 99,000 and -35.76 million in losses. Loss per share was -0.67.
| Revenue | 99,000 |
| Gross Profit | 99,000 |
| Operating Income | -34.22M |
| Pretax Income | -35.76M |
| Net Income | -35.76M |
| EBITDA | -33.84M |
| EBIT | -34.22M |
| Loss Per Share | -0.67 |
Balance Sheet
The company has 26.89 million in cash and 18.21 million in debt, with a net cash position of 8.68 million or 0.16 per share.
| Cash & Cash Equivalents | 26.89M |
| Total Debt | 18.21M |
| Net Cash | 8.68M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 5.27M |
| Book Value Per Share | 0.10 |
| Working Capital | 14.70M |
Cash Flow
In the last 12 months, operating cash flow was -31.15 million and capital expenditures -96,000, giving a free cash flow of -31.24 million.
| Operating Cash Flow | -31.15M |
| Capital Expenditures | -96,000 |
| Free Cash Flow | -31.24M |
| FCF Per Share | -0.58 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -34,568.69% |
| Pretax Margin | -36,116.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PANC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.05% |
| Shareholder Yield | -2.05% |
| Earnings Yield | -66,212,962.96% |
| FCF Yield | -57,857,407.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PANC has an Altman Z-Score of -10.81 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.81 |
| Piotroski F-Score | 1 |